GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt · Delayed Price · Currency is EGP 260.03
-13.41 (-4.90%)
At close: Oct 22, 2026
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 21.72 billion as of October 23, 2026. It is the 16,231st most valuable company in the world and the 41st biggest in Egypt. Its market cap has increased by 263.63% in one year.
Market Cap
21.72B
Enterprise Value
23.30B
Revenue
3.62B
Global Rank
Country Rank
#41 Egypt
PE Ratio
111.84
ChartMarket Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 21.72B, an increase of 3,713.53%. That is a compound annual growth rate of 18.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 21.72B | 308.53% |
| Dec 31, 2025 | 5.32B | 76.81% |
| Dec 31, 2024 | 3.01B | 1.27% |
| Dec 31, 2023 | 2.97B | -6.84% |
| Dec 29, 2022 | 3.19B | 23.58% |
| Dec 30, 2021 | 2.58B | 82.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding